Florida resident Keith Jones says his Affordable Care Act insurance plan was changed multiple times this year without his ...

PsO is a systemic inflammatory disease that presents not only as scaly skin lesions, erythema, and itching but also affects ...

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and NHG Health's Institute of Mental Health (IMH) have mapped how brain networks differ in ...

In a new trial, the Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib increased the rate of survival without disease progression and was well tolerated with a more favorable safety profile when ...

Challenges in clinical trials are unique to each therapeutic area, whether patient recruitment or regulatory compliance. For example, oncology trials require precise endpoint definitions, while ...

EpilepsyGTx, a biotechnology company focused on research and development of cutting-edge gene therapies to treat refractory epilepsy, today announced it has raised $33 million in a Series A financing ...

Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific monoclonal antibody, and daratumumab, a CD38-directed monoclonal antibody, were 83% ...

A new arts and wellbeing program co-developed by the University of South Australia, Flinders University and the University of ...

Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.

Researchers identified trimethylamine (TMA) as a gut microbe–derived metabolite that directly inhibits IRAK4 to reduce ...

Middle-ear infections caused by Gram-negative bacteria remain among the most common pediatric illnesses worldwide.

By analysing nationally representative diet data, researchers show that food additives rarely occur alone, with children and ...